AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
The company said it has been granted approval to import and market trastuzumab deruxtecan used in the treatment of select "HER-2 positive" breast cancer.
"The India approval is based on a global, head-to-head, randomised, open label, registrational Phase III trial DESTINY Breast 03. Globally, trastuzumab deruxtecan is approved in more than 40 countries, including the US, for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer," AstraZeneca Pharma India said in a statement.
HER2 is a form of growth-promoting protein expressed on the surface of multiple tumours, including breast, gastric, lung and colorectal cancers, and is one of the biomarkers expressed in breast cancer tumours, it added.
"India's approval of trastuzumab deruxtecan marks a significant clinical advancement allowing us to help more patients across the HER2 spectrum," AstraZeneca India Country President and Managing Director Sanjeev Panchal said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
"Paris Olympics Turning Point For Indian Sports": PM Modi To Olympians
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert Drugs Regulator Says Will Prioritise Making Regulation System Simpler Parents Gave Names Of Interns, Doctors To CBI In Kolkata Horror: Sources Who Is Jasveen Sangha, "Ketamine Queen" Charged With Matthew Perry's Death How Extreme Weather Is Leading To Rise In Child Marriages In Pakistan 80 Killed In Paramilitary Attack In Sudan OpenAI Blocks Iranian Group's ChatGPT Accounts For Targeting US Election Blinken Heading To Israel To Press Gaza Truce Track Latest News Live on NDTV.com and get news updates from India and around the world.